Success Metrics

Clinical Success Rate
91.9%

Based on 114 completed trials

Completion Rate
92%(114/124)
Active Trials
8(4%)
Results Posted
32%(36 trials)
Terminated
10(6%)

Phase Distribution

Ph phase_2
51
29%
Ph phase_1
19
11%
Ph early_phase_1
1
1%
Ph not_applicable
54
30%
Ph phase_3
22
12%
Ph phase_4
26
15%

Phase Distribution

20

Early Stage

51

Mid Stage

48

Late Stage

Phase Distribution173 total trials
Early Phase 1First-in-human
1(0.6%)
Phase 1Safety & dosage
19(11.0%)
Phase 2Efficacy & side effects
51(29.5%)
Phase 3Large-scale testing
22(12.7%)
Phase 4Post-market surveillance
26(15.0%)
N/ANon-phased studies
54(31.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

88.4%

114 of 129 finished

Non-Completion Rate

11.6%

15 ended early

Currently Active

8

trials recruiting

Total Trials

178

all time

Status Distribution
Active(16)
Completed(114)
Terminated(15)
Other(33)

Detailed Status

Completed114
unknown33
Terminated10
Not yet recruiting7
Recruiting5
Withdrawn5

Development Timeline

Analytics

Development Status

Total Trials
178
Active
8
Success Rate
91.9%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (0.6%)
Phase 119 (11.0%)
Phase 251 (29.5%)
Phase 322 (12.7%)
Phase 426 (15.0%)
N/A54 (31.2%)

Trials by Status

not_yet_recruiting74%
recruiting53%
active_not_recruiting32%
terminated106%
unknown3319%
completed11464%
enrolling_by_invitation11%
withdrawn53%

Recent Activity

Clinical Trials (178)

Showing 20 of 178 trialsScroll for more
NCT03581773Phase 2

Folic Acid Supplement Versus Placebo for Treating Mucositis Adverse Events in Metastatic Renal Cell Carcinoma Patients Receiving Targeted Therapy

Recruiting
NCT05656664Not Applicable

Mitigation Efforts in Arsenic Exposure With Folic Acid Supplementation

Enrolling By Invitation
NCT06015750Phase 4

Mitigate Immune-Mediated Loss of Therapeutic Response to Asfotase Alfa (STRENSIQ®) for Hypophosphatasia

Withdrawn
NCT05062044

A Study to Gather Information About the Progress and Outcomes of Pregnancy in Women Using Various Vitamin Support Plans Before and During Pregnancy

Completed
NCT04744181

Patient Blood Management In CARdiac sUrgical patientS

Completed
NCT06610266Phase 4

Efficacy and Safety of Weifuchun Tablet in Reversing Gastric Intestinal Metaplasia

Recruiting
NCT05284656Phase 3

Effect of Folic Acid and/or Pentoxifylline on Patients With Chronic Kidney Disease

Active Not Recruiting
NCT05096663Phase 2

Testing the Use of Combination Immunotherapy Treatment (N-803 [ALT-803] Plus Pembrolizumab) Against the Usual Treatment for Advanced Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)

Active Not Recruiting
NCT05289908Phase 1

Intrathecal Pemetrexed for Leptomeningeal Metastasis

Completed
NCT06935630Not Applicable

Comparison of The Effect of 5-MTHF and Folic Acid Supplementation in Increasing Red Blood Cell Folate in Pregnant Women

Recruiting
NCT02947750Phase 2

Neurovascular Transduction During Exercise in Chronic Kidney Disease

Recruiting
NCT04016090Not Applicable

An Evaluation of Folic Acid to Improve Endothelial Sensitivity to Shear Stress in Seniors

Completed
NCT06641245Not Applicable

PREconception Folic Acid Clinical Efficacy (PREFACE) Trial

Not Yet Recruiting
NCT06481696Not Applicable

Possible Action of Resveratrol in Improving the Outcomes of IVF/ICSI in Couples With Unexplained Infertility

Recruiting
NCT03994731Phase 4

Study of KRYSTEXXA® (Pegloticase) Plus Methotrexate in Participants With Uncontrolled Gout

Completed
NCT03635957Phase 4

Study of Pegloticase (KRYSTEXXA®) Plus Methotrexate in Patients With Uncontrolled Gout

Completed
NCT06220461Not Applicable

Folic Acid Supplementation to Reduce Anemia in Extremely Preterm Infants

Not Yet Recruiting
NCT06405204Phase 3

of Myo-inositol, Melatonin and Co-enzyme q10 on Ovarian Reserve

Not Yet Recruiting
NCT03853304Not Applicable

Quadruple Fortified Salt Trial in India

Active Not Recruiting
NCT06267053

Relationship Between Vitamins and Radiologic Stage in Knee Osteoarthritis

Completed

Drug Details

Intervention Type
DRUG
Total Trials
178